GNAS
GNAS Methylation-Specific MLPA
GNAS Methylation-Specific MLPA
GNAS methylation-specific MLPA is a molecular test that detects methylation abnormalities and copy number variants GNAS complex locus on chromosome 20q13.32. This test can also confirm a diagnosis and identify disease-causing variants within a family to facilitate carrier screening.
Pseudohypoparathyroidism (PHP), Pseudopseudohypoparathyroidism (PPHP), Osteoma cutis, Progressive osseous heteroplasia
Clinical Information
Pseudohypoparathyroidism (PHP) is caused by inactivation of GNAS. There are multiple PHP phenotypes resulting from GNAS inactivation, including PHP -Ia, -Ib, and –Ic. Additional phenotypes include pseudopseudohypoparathyroidism (PPHP), progressive osseous heteroplasia (POH), and osteoma cutis (OC). These disorders are associated with varying degrees of hormone resistance and skeletal abnormalities including short stature, subcutaneous ossifications, and brachydactyly.
GNAS is an imprinted locus on chromosome 20q13.32 with a primary mechanism for GNAS inactivation resulting from methylation defects. Epigenetic inactivation of GNAS can occur through paternal uniparental disomy, isolated epivariants, and alterations in regulatory elements of GNAS or STX16.
Disorders of GNAS inactivation are examples of disorders involving imprinted genes. Imprinted genes are only expressed from either the maternally or paternally derived member of a homologous chromosome pair. Disorders of GNAS inactivation are caused by the lack of expression of GNAS. PHP -Ia, -Ib, and –Ic are caused by inactivation of the maternal GNAS complex locus while PPHP, POH, and OC are caused by inactivation of the paternal GNAS complex locus.
Technical Information
Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) analysis is performed to determine if deletions, duplications or methylation defects involving the GNAS complex locus on 20q13.32 are present. MS-MLPA analysis allows for the determination of dosage for specific sequences of interest as well as for methylation status at several differentially methylated HhaI restriction sites (Schouten et al. (2002) Nucleic Acids Research 30, e57).
Genomic DNA is hybridized with probes that correspond to CpG islands in the promoters of GNAS-NESP, GNAS-AS1, GNAS-XL, and GNAS-A/B to determine dosage and methylation status of the genes in those regions. This assay also includes probes to detect deletions or duplications in the STX16 gene, which serves as a long-range control element of methylation at the GNAS locus.
Specimen Requirements
Transport Instructions
Associated Tests
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
